+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The expression of kappa opioid receptor messenger RNA in the hippocampus and the entorhinal cortex of Alzheimers disease patient



The expression of kappa opioid receptor messenger RNA in the hippocampus and the entorhinal cortex of Alzheimers disease patient



Society for Neuroscience Abstracts 21(1-3): 1623




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033809577

Download citation: RISBibTeXText


Related references

Highly polysialylated neural cell adhesion molecule expression in the entorhinal cortex and hippocampus Changes in temporal lobe epilepsy and Alzheimers disease. Society for Neuroscience Abstracts 24(1-2): 1420, 1998

N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. Journal of the Neurological Sciences 200(1-2): 11-18, 2002

The protein encoded by padhc9 sgp2 is expressed in alzheimers disease hippocampus and is elevated in the rat hippocampus following entorhinal cortex lesion. Society for Neuroscience Abstracts 16(2): 1269, 1990

Non-NMDA glutamate receptor subunit expression in the entorhinal cortex of patients with Alzheimers disease and normal controls. Society for Neuroscience Abstracts 19(1-3): 222, 1993

Synaptophysin-like immunoreactivity in the hippocampus and the entorhinal cortex of patients with Alzheimers disease and in aged controls. Society for Neuroscience Abstracts 19(1-3): 834, 1993

Microglial Exosomes Propagate Tau Protein From The Entorhinal Cortex To The Hippocampus: An Early Pathophysiology Of AlzheimerS Disease. Alzheimer's & Dementia 12(7): P339-P340, 2016

Regional and temporal differences in mu, delta, and kappa opioid receptor expression by murine type 1 astrocytes from the cerebral cortex, hippocampus, cerebellum, and striatum in vitro. Society for Neuroscience Abstracts 21(1-3): 1360, 1995

GABA A receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus. Journal of Neurochemistry 145(5): 374-392, 2018

Statin, a marker of cell cycle arrest is increased in CA1 neurons of the hippocampus in Alzheimers disease and in entorhinal cortex lesioned rats. Society for Neuroscience Abstracts 19(1-3): 884, 1993

Astrocytic apolipoprotein e messenger rna and gfap messenger rna in hippocampus after entorhinal cortex lesioning. Molecular Brain Research 11(2): 97-106, 1991

Neuronal loss, neurofibrillary tangles and senile plaques in normal aging and Alzheimers disease A quantitative study of the hippocampus and the entorhinal cortex. Neurobiology of Aging 17(4 Suppl. ): S119, 1996

Glutamate receptor expression changes in rat hippocampus after entorhinal cortex lesion. Society for Neuroscience Abstracts 18(1-2): 90, 1992

GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. Journal of Pharmacology and Experimental Therapeutics 283(3): 1342-1349, 1997

LDL receptor expression during synaptic remodelling in the hippocampus following entorhinal cortex lesioning. Society for Neuroscience Abstracts 18(1-2): 607, 1992

Corticosterone decreases glial fibrillary acidic protein messenger rna and sulfated glycoprotein 2 messenger rna in the hippocampus of adrenalectomized and entorhinal cortex lesioned male rats. Society for Neuroscience Abstracts 16(1): 659, 1990